Efficacy and Safety of Hypofractionated Radiotherapy for the Treatment of Newly Diagnosed Glioblastoma Multiforme: A Systematic Review and Meta-Analysis-Reference-Cited by-同舟云学术

Efficacy and Safety of Hypofractionated Radiotherapy for the Treatment of Newly Diagnosed Glioblastoma Multiforme: A Systematic Review and Meta-Analysis

Published:2019-10-14 Issue: Volume:9 Page:
ISSN:2234-943X
Container-title:Frontiers in Oncology
language:
Short-container-title:Front. Oncol.

Author:

Liao Guixiang,Zhao Zhihong,Yang Hongli,Li Xianming

Publisher

Frontiers Media SA

Subject

Cancer Research,Oncology

Reference47 articles.

1. CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2009–2013;Ostrom;Neuro Oncol.,2016

2. Bevacizumab plus radiotherapy-temozolomide for newly diagnosed glioblastoma;Chinot;N Engl J Med,2014

3. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial;Stupp;Lancet Oncol,2009

4. Stereotactic radiosurgery and hypofractionated radiotherapy for glioblastoma;Shah;Neurosurgery,2018

5. Hypofractionated-intensity modulated radiotherapy (hypo-IMRT) and temozolomide (TMZ) with or without bevacizumab (BEV) for newly diagnosed glioblastoma multiforme (GBM): a comparison of two prospective phase II trials;Carlson;J Neurooncol,2015

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Programmed cell death disrupts inflammatory tumor microenvironment (TME) and promotes glioblastoma evolution;Cell Communication and Signaling;2024-06-18

2. BCL6 is a context-dependent mediator of the glioblastoma response to irradiation therapy;International Journal of Biological Macromolecules;2024-06

3. Biological Dose Escalation—Do We Have a New Window of Opportunity in High-Grade Glioma?—A Feasibility Study;South Asian Journal of Cancer;2024-02-12

4. Survival of elderly patients with glioblastoma after hypofractionated radiation therapy;Український радіологічний та онкологічний журнал;2023-09-30

5. Evaluating the role of HYpofractionated RAdiotherapy schedule in High Grade GlioMA patients less than 60 years of age during the COVID period- A single Institutional Prospective Observational Study (HYRAMA study);2023-06-26